- Tekton was founded in 2006
- Based in Dallas, Dallas-based Havencrest Capital Management invests in healthcare
- The firm has approximately $600 million of assets under management
Havencrest Capital Management has made a majority investment in Tekton Research LLC, a Austin-based clinical trial site network. No financial terms were disclosed.
Founded in 2006, Tekton conducts clinical trials across several therapeutic areas, including vaccines and infectious disease, neurology, endocrinology, immunology and dermatology, among others.
